A genetic test for immunosuppressant dose selection?

Pharmacogenetics. 2004 Mar;14(3):145-6. doi: 10.1097/00008571-200403000-00001.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cohort Studies
  • Cyclosporine / administration & dosage
  • Cyclosporine / pharmacokinetics*
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / genetics*
  • Dose-Response Relationship, Drug
  • Drug Resistance, Multiple / genetics
  • Genotype
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacokinetics*
  • Kidney Transplantation / immunology
  • Multidrug Resistance-Associated Proteins / genetics*
  • Polymorphism, Genetic / genetics*
  • Tacrolimus / administration & dosage
  • Tacrolimus / pharmacokinetics*

Substances

  • Immunosuppressive Agents
  • Multidrug Resistance-Associated Proteins
  • Cyclosporine
  • Cytochrome P-450 Enzyme System
  • CYP3A protein, human
  • Cytochrome P-450 CYP3A
  • Tacrolimus
  • multidrug resistance-associated protein 1